MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on May 11, 2006; DOI: 10.1124/mol.105.016451


0026-895X/06/7002-532-541$20.00
Mol Pharmacol 70:532-541, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
mol.105.016451v1
70/2/532    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, Q.
Right arrow Articles by Zhang, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, Q.
Right arrow Articles by Zhang, Y.

Mammalian Tolloid Alters Subcellular Localization, Internalization, and Signaling of {alpha}1a-Adrenergic ReceptorsFormula

Qi Xu, Ning Xu, Tan Zhang, Hui Zhang, Zijian Li, Feng Yin, Zhizhen Lu, Qide Han, and Youyi Zhang

Institute of Vascular Medicine, Peking University Third Hospital and Key Laboratory of Molecular Cardiovascular Sciences, Ministry of Education, Beijing, China

In the present study, we identified the CUB5 domain of mammalian Tolloid (mTLD) as a novel protein binding to {alpha}1A-adrenergic receptor (AR) using the yeast two-hybrid system. Whereas CUB5 did not couple to either {alpha}1B-AR or {alpha}1D-AR. It was determined that amino acids 322 to 359 of {alpha}1A-AR were the major binding region for CUB5. The direct interaction between {alpha}1A-AR cytoplasmic tail and CUB5 was discovered by glutathione S-transferase pull-down assay. We confirmed the interaction of mTLD with {alpha}1A-AR in human embryonic kidney (HEK) 293 cells by immunoprecipitation, immunofluorescence, and fluorescence resonance energy transfer. Although mTLD did not affect the density and affinity of receptors in crudely prepared membranes from HEK293 cells stably expressing {alpha}1A-AR, it significantly altered the subcellular localization of the receptors. Moreover, mTLD reduced the level of cell surface {alpha}1A-ARs, delayed the initial rate of agonist-induced receptor internalization, and facilitated agonist-induced calcium transient. We have demonstrated that mTLD interacts with {alpha}1A-AR directly, alters the subcellular localization of receptor, and influences agonist-induced {alpha}1A-AR internalization and calcium signaling.


Received July 4, 2005; accepted May 11, 2006

Address correspondence to: Youyi Zhang, Institute of Vascular Medicine, Peking University Third Hospital, No.49 Huayuan North Road, Haidian District, Beijing, P.R. China 100083. E-mail: zhangyy{at}bjmu.edu.cn







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics